In the U.S., it is legal for merchants to mislead consumers in this way. Monsanto has bet the company's future on genetically- engineered products, and rBGH is the first such product to be marketed. Therefore, it seems unlikely that Monsanto will voluntarily terminate the uncontrolled IGF-1 experiment being conducted now on the American people. This is a company that plays hard ball. Lappe is an established medical writer and an acknowledged health policy expert.
Subscriptions are free.
We would like to continue to provide this service free. Please do not send credit card information via E-mail.